Citation Impact
Citing Papers
Cardiac Risk of Noncardiac Surgery after Percutaneous Coronary Intervention with Drug-eluting Stents
2008
Two-Year Follow-Up of the Quantitative Angiographic and Volumetric Intravascular Ultrasound Analysis After Nonpolymeric Paclitaxel-Eluting Stent Implantation
2006
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study
2009 StandoutNobel
CYP2C19*2/ABCB1-C3435T polymorphism and risk of cardiovascular events in coronary artery disease patients on clopidogrel: Is clinical testing helpful?
2012
Synthesis of metallic nanoparticles using plant extracts
2013 Standout
Influence of Genetic Polymorphisms on the Effect of High- and Standard-Dose Clopidogrel After Percutaneous Coronary Intervention
2012
Microbubbles in ultrasound-triggered drug and gene delivery
2008 Standout
Effect of Surface Properties on Nanoparticle–Cell Interactions
2009 Standout
Surveillance and prevention of major perioperative ischemic cardiac events in patients undergoing noncardiac surgery: a review
2005
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
2004 Standout
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
2013 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy
2004
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
2010
Mini-Crush Versus T-Provisional Techniques in Bifurcation Lesions
2009
Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis
2010
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
2003 Standout
Pathology of Drug-Eluting Stents in Humans
2006 Standout
Perioperative Management of Antithrombotic Therapy
2012 Standout
Pharmacogenetic Testing for Clopidogrel Using the Rapid INFINITI Analyzer
2009
Nanopesticide research: Current trends and future priorities
2013 Standout
Oral Anticoagulant Therapy
2012 Standout
PLGA-based nanoparticles: An overview of biomedical applications
2012 Standout
Two‐year clinical outcome after coronary stenting of small vessels using 2.25‐mm sirolimus‐ and paclitaxel‐eluting stents: Insight into the RESEARCH and T‐SEARCH registries
2006
Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients
2007
CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study
2010
Genetic Polymorphisms and the Impact of a Higher Clopidogrel Dose Regimen on Active Metabolite Exposure and Antiplatelet Response in Healthy Subjects
2011
The relation between CYP2C19 genotype and phenotype in stented patients on maintenance dual antiplatelet therapy
2011
Hydrogel nanoparticles in drug delivery
2008 Standout
A Second-Generation, Endoluminal, Flow-Disrupting Device for Treatment of Saccular Aneurysms
2009
Mitochondria: In Sickness and in Health
2012 Standout
Fractional Flow Reserve versus Angiography for Guiding Percutaneous Coronary Intervention
2009 Standout
Value of platelet pharmacogenetics in common clinical practice of patients with ST-segment elevation myocardial infarction
2012
CYP2C9 Genotype-guided Warfarin Prescribing Enhances the Efficacy and Safety of Anticoagulation: A Prospective Randomized Controlled Study
2007
Biodegradable polymeric nanoparticles based drug delivery systems
2009 Standout
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
2010
ABCB1 C3435T Polymorphism and Response to Clopidogrel Treatment in Coronary Artery Disease (CAD) Patients: A Meta-Analysis
2012
Systemic targeted delivery of antisense with perflourobutane gas microbubble carrier reduced neointimal formation in the porcine coronary restenosis model
2003
Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues
2008 Standout
Management of Patients With Ulcer Bleeding
2012 Standout
Drug eluting stents: are human and animal studies comparable?
2003
Antirestenotic Effects of a Novel Polymer-Coated D-24851 Eluting Stent. Experimental Data in a Rabbit Iliac Artery Model
2007
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
A Paclitaxel-Eluting Stent for the Prevention of Coronary Restenosis
2003
Relation of CYP2C19 loss-of-function polymorphism to the occurrence of stent thrombosis
2010
Pipeline for Uncoilable or Failed Aneurysms: Results from a Multicenter Clinical Trial
2013 Standout
Immediate and Midterm Results following Treatment of Unruptured Intracranial Aneurysms with the Pipeline Embolization Device
2011
Topological design and additive manufacturing of porous metals for bone scaffolds and orthopaedic implants: A review
2016 Standout
Cytochrome P450 2C19 polymorphism is associated with poor clinical outcomes in coronary artery disease patients treated with clopidogrel
2010
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Impact of Cytochrome P450 2C19 Loss-of-Function Polymorphism and of Major Demographic Characteristics on Residual Platelet Function After Loading and Maintenance Treatment With Clopidogrel in Patients Undergoing Elective Coronary Stent Placement
2010
Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery
2003 Standout
The effect of CYP2C19 gene polymorphisms on the pharmacokinetics and pharmacodynamics of prasugrel 5-mg, prasugrel 10-mg and clopidogrel 75-mg in patients with coronary artery disease
2014 StandoutNobel
The Effects of Paclitaxel on the Three Phases of Restenosis
2004
Long-Term Outcomes After Management of Restenosis or Thrombosis of Drug-Eluting Stents
2006
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Pilot Study of the Antiplatelet Effect of Increased Clopidogrel Maintenance Dosing and Its Relationship to CYP2C19 Genotype in Patients With High On-Treatment Reactivity
2010
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion
2016 Standout
Spotty Calcification Typifies the Culprit Plaque in Patients With Acute Myocardial Infarction
2004
A review of shape memory alloy research, applications and opportunities
2013 Standout
2011 Update to The Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists Blood Conservation Clinical Practice Guidelines
2011 Standout
Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting Stents
2005 Standout
Differential Response of Delayed Healing and Persistent Inflammation at Sites of Overlapping Sirolimus- or Paclitaxel-Eluting Stents
2005
Drug Release Kinetics from Biodegradable Polymers via Partial Differential Equations Models
2012
Coated Stents for the Prevention of Restenosis: Part II
2002
Biomedical Applications of Shape Memory Alloys
2011
Prediction of protein function and pathways in the genome era
2004
Mechanisms of Plaque Formation and Rupture
2014 Standout
Endovascular Treatment of Intracranial Aneurysms With Flow Diverters
2013 Standout
Clopidogrel Pharmacogenomics and Risk of Inadequate Platelet Inhibition: US FDA Recommendations
2009
Classification of Intrinsically Disordered Regions and Proteins
2014 Standout
Sustained Reduction of In-Stent Neointimal Growth With the Use of a Novel Systemic Nanoparticle Paclitaxel
2002
Biodegradable nanoparticles for drug and gene delivery to cells and tissue
2012
Shape Memory Materials for Biomedical Applications
2002
Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents
2012
Controlled Ring-Opening Polymerization of Lactide and Glycolide
2004 Standout
Clinical End Points in Coronary Stent Trials
2007 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Cytochrome P450 Genetic Polymorphisms and the Response to Prasugrel
2009
Vascular Responses to Drug Eluting Stents
2007
Soft Robotic Grippers
2018 Standout
Metallic implant biomaterials
2014 Standout
ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
2010
KDOQI Clinical Practice Guideline for Vascular Access: 2019 Update
2020 Standout
Augmentation of Wall Shear Stress Inhibits Neointimal Hyperplasia After Stent Implantation
2003
Strut Position, Blood Flow, and Drug Deposition
2005
Vascular Calcification
2006 Standout
2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes
2014 Standout
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
2011 Standout
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
2010
Vascular Calcification
2008 Standout
Iron-based shape memory alloy strips for strengthening RC members: Material behavior and characterization
2018 Standout
ACCF/ACG/AHA 2010 Expert Consensus Document on the Concomitant Use of Proton Pump Inhibitors and Thienopyridines: A Focused Update of the ACCF/ACG/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use
2010
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Inorganic Nanoparticles for MRI Contrast Agents
2009 Standout
Review of progress in shape-memory polymers
2007 Standout
Works of Douglas Scott being referenced
Progressive vascular remodeling and reduced neointimal formation after placement of a thermoelastic self-expanding nitinol stent in an experimental model
1998
Pathologic validation of a new method to quantify coronary calcific deposits in vivo using intravascular ultrasound
2000
PLATINUM QCA: a prospective, multicentre study assessing clinical, angiographic, and intravascular ultrasound outcomes with the novel platinum chromium thin-strut PROMUS Element everolimus-eluting stent in de novo coronary stenoses
2011
The Antiplatelet Effect of Higher Loading and Maintenance Dose Regimens of Clopidogrel
2008
Drug‐eluting stents for coronary bifurcations: Bench testing of provisional side‐branch strategies
2005
The Pharmacogenetics and Pharmacodynamics of Clopidogrel Response
2008
Stent design favorably influences the vascular response in normal porcine coronary arteries.
1999
Dose-Response Effects of 32 P Radioactive Stents in an Atherosclerotic Porcine Coronary Model
1999
Pathological Analysis of Local Delivery of Paclitaxel Via a Polymer-Coated Stent
2001